MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$16,988K
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
0 718 132 6,272
Payroll and payroll-related expenses
-2,394* --
Total direct program expenses
-3,874* --
Other research and development expenses
-321* --
Research and development
11,181 6,588 5,870 6,465
General and administrative
6,665 6,423 6,785 4,880
Total operating expenses
17,846 13,011 12,655 11,345
Loss from operations
-17,846 -12,293 -12,523 -5,073
Other income (expense), net
858 21,957 365 389
Gain before provision for income taxes
-16,988 9,663 -12,158 -4,684
Provision for income taxes
0 0 0 0
Net gain
-16,988 9,663 -12,158 -4,684
Basic EPS
0 9,538.993 -168.01 -
Diluted EPS
0 9,538.993 -168.01 -
Basic Average Shares
0 1,013 1,250 -
Diluted Average Shares
0 1,013 1,250 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net gain-$16,988K (-65.98%↓ Y/Y)Gain beforeprovision for income taxes-$16,988K (-65.98%↓ Y/Y)Other income(expense), net$858K (-62.94%↓ Y/Y)Loss from operations-$17,846K (-42.20%↓ Y/Y)Total operatingexpenses$17,846K (40.74%↑ Y/Y)Research and development$11,181K (67.91%↑ Y/Y)General andadministrative$6,665K (10.70%↑ Y/Y)

Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Inc. (OVID)